Welcome
Welcome to the Pherecydes Pharma investor website,
Here you will find all the financial information dedicated to shareholders and investors.
Press release
03/27/2023 - 07:00
Pherecydes Pharma selected for the French Tech Health20 program’s 2023 class
01/03/2023 - 17:45
Pherecydes Pharma Announces its Financial Agenda for 2023
Subscribe to email alert
Ask us your questions
Contacts
Pherecydes Pharma
Thibaut du Fayet
CEO
Email : This email address is being protected from spambots. You need JavaScript enabled to view it.
NewCap
Investor Relations & Strategic Communication
Dusan Oresansky
+33 (0)1 44 71 94 92
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Medias Relations
Nicolas Merigeau
+33 (0)1 44 71 94 98
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.